During this presentation Aasma Shaukat, MD, MPH, FASGE, presents how to assemble an adenoma detection rate (ADR) improvement toolkit for your practice. ADR is a validated quality indicator and a reportable quality metric for CMS. Multiple studies have found that low ADRs are associated with higher risk of interval colorectal cancer. ADR benchmarks set by the US multi-society task force are 30% for men and 20% for women undergoing screening colonoscopy. Doug Rex, MD, FASGE, joins Dr. Shaukat during the Q&A session at the close of the presentation.

The live event took place February 21, 2019.